Leiden Mutation

Causes

• Genetic Mutation:
  • The mutation is a single point mutation (a change in one building block of DNA) in the F5 gene, located on chromosome 1.
  • This specific mutation changes an amino acid in the Factor V protein, making it resistant to inactivation by activated Protein C (APC). APC is a natural anticoagulant that helps slow down clotting.
• Inheritance Pattern:
  • Autosomal Dominant: You only need to inherit one copy of the mutated gene from one parent to have Factor V Leiden.
  • Heterozygous: Inheriting one copy of the mutated gene (from one parent). This is the most common form and carries a moderately increased risk of clotting (3-8 times the normal risk).
  • Homozygous: Inheriting two copies of the mutated gene (one from each parent). This is rarer but carries a significantly higher risk of clotting (up to 80 times the normal risk) and often leads to earlier and more severe clotting events.
• Increased Risk of Clotting: The mutation itself does not guarantee a clot, but it significantly increases the risk, especially when combined with other factors.

Symptoms

• Symptoms of Deep Vein Thrombosis (DVT):
  • Pain or tenderness in the affected limb (most commonly leg or thigh).
  • Swelling of the affected limb.
  • Redness or discoloration of the skin.
  • Warmth in the affected area.
  • Often, a heavy or aching sensation in the leg.
• Symptoms of Pulmonary Embolism (PE):
  • Sudden shortness of breath.
  • Chest pain (often sharp, worse with deep breath).
  • Rapid heart rate.
  • Coughing (may include bloody mucus).
  • Dizziness or lightheadedness.
  • Sweating.
  • Anxiety.
  • These are life-threatening symptoms and require immediate medical attention.
• Other Less Common Clotting Events:
  • Cerebral Vein Thrombosis: Blood clot in the veins of the brain, causing severe headache, seizures, or neurological deficits.
  • Mesenteric Ischemia: Blood clot in the arteries or veins supplying the intestines, causing severe abdominal pain.
  • Recurrent Miscarriages: Increased risk of recurrent pregnancy loss due to blood clots in the placenta.

Diagnosis

• Medical History: The doctor will inquire about any personal history of blood clots (DVT, PE, stroke, heart attack) and any family history of clotting disorders.
• Blood Tests:
  • Activated Protein C (APC) Resistance Test: This initial screening test checks how well Factor V responds to inactivation by Protein C. If it's resistant, it suggests Factor V Leiden.
  • Genetic Test for F5 Gene Mutation: If the APC resistance test is abnormal, a specific DNA test confirms the presence of the Factor V Leiden mutation. This test can determine if a person is heterozygous (one copy) or homozygous (two copies) for the mutation.
• Imaging Tests (if a clot is suspected):
  • Duplex Ultrasound: For diagnosing DVT in the legs.
  • CT Pulmonary Angiogram (CTPA): For diagnosing PE in the lungs.

Treatment

• For Individuals with a History of Blood Clots:
  • Anticoagulant Medications (Blood Thinners):
    • Warfarin (Coumadin): A common treatment that reduces the ability of blood to clot. Requires regular blood tests (INR) to monitor.
    • Direct Oral Anticoagulants (DOACs): (e.g., rivaroxaban, apixaban, dabigatran, edoxaban) Newer blood thinners that do not require frequent monitoring. Often used for treating acute clots and preventing recurrence.
  • The duration of anticoagulant therapy depends on the individual's clot history, type of clot, and other risk factors. It may be short-term (e.g., 3-6 months) or lifelong.
• For Asymptomatic Individuals with Factor V Leiden (No History of Clots):
  • Lifelong blood thinners are generally *not* recommended as a primary prevention strategy due to bleeding risks.
  • Risk Factor Management: Focus on avoiding or mitigating other clotting risk factors.
  • Prophylaxis in High-Risk Situations: Anticoagulants may be temporarily used during periods of increased risk, such as:
    • Surgery or prolonged immobility.
    • Long-haul flights (discuss with doctor).
    • Pregnancy and postpartum period (heparin injections often used).
    • Use of estrogen-containing birth control pills or hormone replacement therapy (often advised against due to significantly increased clot risk).
• For Pregnant Women with Factor V Leiden:
  • Often prescribed low molecular weight heparin (LMWH) injections during pregnancy and postpartum to prevent clots, especially if there's a history of clots or pregnancy loss.
• Lifestyle Modifications:
  • Maintain a healthy weight.
  • Regular exercise.
  • Avoid prolonged immobility (e.g., get up and move during long flights/car rides).
  • Quit smoking.
  • Stay hydrated.

Living With Factor V Leiden

Most people who carry factor V Leiden never have a clot, so the practical work is a handful of decisions: who else should be tested, what to do about hormones, how long to treat a clot if one happens, and how to handle the situations that raise risk.

Who should be tested, and when it changes nothing

Testing is most useful for first-degree relatives who are considering estrogen-containing birth control, hormone therapy, or a pregnancy, because the result changes what is prescribed. It is less useful after an unprovoked clot, since the decision to extend treatment is driven more by the clot than by the gene. The hypercoagulation states page covers the other tendencies checked at the same time, including the lupus anticoagulant and anticardiolipin antibodies, which are managed differently.

Hormones: the decision that matters most for women

Combined estrogen pills, patches, and rings multiply the clot risk of the mutation, so they are avoided; progestin-only methods and intrauterine devices are the usual alternatives. At menopause, our hormone therapy risks and benefits article explains why transdermal estrogen is preferred over tablets when treatment is needed at all. In pregnancy, daily enoxaparin is prescribed for carriers with a prior clot or strong family history and continued about six weeks after delivery, the period of highest risk.

After a clot: how long to treat

A deep vein thrombosis or pulmonary embolism provoked by surgery or immobility is treated for about three months whether or not the mutation is present. Carrying one copy does not on its own mean lifelong treatment; two copies, a second clot, a clot with no trigger, or a combination with another clotting tendency usually does. Apixaban and rivaroxaban are the usual choices, and a reduced dose of either is used for long-term prevention; warfarin remains the option when kidney function or cost rules them out.

Travel, surgery, and hospital stays

For flights or drives longer than about four hours, walk the aisle hourly, keep hydrated, avoid alcohol, and wear knee-high compression stockings; our blood clots and snowbird travel guide covers the specifics. Tell every surgeon about the mutation before a procedure, because prophylaxis may be extended; the same applies to a hospital admission or a leg cast.

Knowing the symptoms cold

One-sided calf or thigh swelling with aching, or sudden breathlessness with sharp chest pain and a fast pulse, is evaluated the same day, and a carrier should say so at triage. Our hematology team coordinates testing and treatment duration decisions. MedlinePlus Genetics and the CDC publish patient guidance on the mutation and on recognizing clots.

If you carry factor V Leiden and are considering hormones, pregnancy, or surgery, or a relative was just diagnosed, schedule a visit.